138 related articles for article (PubMed ID: 7201110)
1. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
[TBL] [Abstract][Full Text] [Related]
2. Plasma exchange in multiple sclerosis.
Guarnieri BM; Capparelli R; Fratiglioni L; Inzitari D; Sità D; Amaducci L; Avanzi G; Biani D; Franco C; Lombardo R
Int J Artif Organs; 1985 Jul; 8(4):215-20. PubMed ID: 3902665
[No Abstract] [Full Text] [Related]
3. Intravenous immunoglobulin, plasmalymphocytapheresis and azathioprine in chronic progressive multiple sclerosis.
Uccelli A; Capello E; Fenoglio D; Incagliato M; Valbonesi M; Mancardi GL
Ital J Neurol Sci; 1994 Feb; 15(1):51-3. PubMed ID: 8206747
[TBL] [Abstract][Full Text] [Related]
4. Plasmapheresis in multiple sclerosis: preliminary findings.
Dau PC; Petajan JH; Johnson KP; Panitch HS; Bornstein MB
Neurology; 1980 Oct; 30(10):1023-8. PubMed ID: 6448360
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchange combined with azathioprine in multiple sclerosis using serial gadolinium-enhanced MRI to monitor disease activity: a randomized single-masked cross-over pilot study.
Sørensen PS; Wanscher B; Szpirt W; Jensen CV; Ravnborg M; Christiansen P; Schreiber K; Nordenbo A
Neurology; 1996 Jun; 46(6):1620-5. PubMed ID: 8649560
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with azathioprine: the pros.
Ellison GW; Myers LW; Mickey MR; Graves MC; Tourtellotte WW; Nuwer MR
Neurology; 1988 Jul; 38(7 Suppl 2):20-3. PubMed ID: 3290709
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.
Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Weiner HL
Arch Neurol; 1983 Oct; 40(11):687-90. PubMed ID: 6354151
[No Abstract] [Full Text] [Related]
8. Plasma exchange and immunosuppression in rapidly progressive glomerulonephritis: a controlled, multi-center study.
Glöckner WM; Sieberth HG; Wichmann HE; Backes E; Bambauer R; Boesken WH; Bohle A; Daul A; Graben N; Keller F
Clin Nephrol; 1988 Jan; 29(1):1-8. PubMed ID: 3289804
[TBL] [Abstract][Full Text] [Related]
9. Plasmapheresis in multiple sclerosis: preliminary study.
Weiner HL; Dawson DM
Neurology; 1980 Oct; 30(10):1029-33. PubMed ID: 7191492
[TBL] [Abstract][Full Text] [Related]
10. [Plasmapheresis and immunosuppressive drugs in the treatment of multiple sclerosis].
Cendrowski W
Neurol Neurochir Pol; 1984; 18(3):259-62. PubMed ID: 6390235
[No Abstract] [Full Text] [Related]
11. A double-blind controlled pilot study of plasma exchange versus sham apheresis in chronic progressive multiple sclerosis.
Gordon PA; Carroll DJ; Etches WS; Jeffrey V; Marsh L; Morrice BL; Olmstead D; Warren KG
Can J Neurol Sci; 1985 Feb; 12(1):39-44. PubMed ID: 3884114
[TBL] [Abstract][Full Text] [Related]
12. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
13. [Plasmapheresis in multiple sclerosis].
Fuchs S; Pogglitsch H; Ladurner G; Lechner H
Wien Klin Wochenschr; 1984 Jan; 96(2):67-9. PubMed ID: 6710999
[TBL] [Abstract][Full Text] [Related]
14. The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.
D'Amico E; Leone C; Graziano G; Amato MP; Bergamaschi R; Cavalla P; Coniglio G; Di Battista G; Ferrò MT; Granella F; Granieri E; Lugaresi A; Lus G; Millefiorini E; Pozzilli C; Tedeschi G; Zappia M; Comi G; Trojano M; Lepore V; Patti F
PLoS One; 2016; 11(6):e0157721. PubMed ID: 27348606
[TBL] [Abstract][Full Text] [Related]
15. Plasma exchange (PE) and lymphocytapheresis (LCA) in multiple sclerosis (MS).
Höcker P; Stellamor V; Summer K; Mann M
Int J Artif Organs; 1984 Jan; 7(1):39-42. PubMed ID: 6698632
[TBL] [Abstract][Full Text] [Related]
16. Intensive immunosuppression in the treatment of multiple sclerosis.
Ring J; Seifert J; Lob G; Coulin K; Angstwurm H; Frick E; Brass B; Mertin J; Backmund H; Brendel W
Lancet; 1974 Nov; 2(7889):1093-6. PubMed ID: 4139403
[No Abstract] [Full Text] [Related]
17. A comprehensive protocol for clinical trials in multiple sclerosis which favored azathioprine and corticosteroid as a type of treatment for the chronic progressive phase.
Tourtellotte WW; Syndulko K; Baumhefner RW; Shapshak P; Osborne M
Neurology; 1988 Jul; 38(7 Suppl 2):83-6. PubMed ID: 3386848
[No Abstract] [Full Text] [Related]
18. Immunological treatment of multiple sclerosis. II.
Hughes RA
J Neurol; 1986 Apr; 233(2):66-8. PubMed ID: 3009722
[No Abstract] [Full Text] [Related]
19. Thymectomy in multiple sclerosis. Two preliminary trials.
Ferguson TB; Clifford DB; Montgomery EB; Bruns KA; McGregor PJ; Trotter JL
J Thorac Cardiovasc Surg; 1983 Jan; 85(1):88-93. PubMed ID: 6848891
[TBL] [Abstract][Full Text] [Related]
20. Azathioprine in multiple sclerosis: the cons.
Silberberg DH
Neurology; 1988 Jul; 38(7 Suppl 2):24-7. PubMed ID: 3290710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
